0000950170-24-050854.txt : 20240430
0000950170-24-050854.hdr.sgml : 20240430
20240430214506
ACCESSION NUMBER: 0000950170-24-050854
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240426
FILED AS OF DATE: 20240430
DATE AS OF CHANGE: 20240430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacques Rachelle Suzanne
CENTRAL INDEX KEY: 0001772610
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36288
FILM NUMBER: 24899733
MAIL ADDRESS:
STREET 1: C/O CORBUS PHARMACEUTICALS HOLDINGS, INC
STREET 2: 100 RIVER RIDGE DRIVE
CITY: NORWOOD
STATE: MA
ZIP: 02062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akari Therapeutics Plc
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF ROAD
STREET 2: FL 7
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (646) 350-0702
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF ROAD
STREET 2: FL 7
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Celsus Therapeutics Plc.
DATE OF NAME CHANGE: 20130621
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
4
1
ownership.xml
4
X0508
4
2024-04-26
0001541157
Akari Therapeutics Plc
AKTX
0001772610
Jacques Rachelle Suzanne
C/O AKARI THERAPEUTICS, PLC
22 BOSTON WHARF ROAD FL 7
BOSTON
MA
02210
true
true
false
false
Chief Executive Officer
false
Ordinary Shares, par value $0.0001 per share
2024-04-26
4
A
false
479569892
0.00
A
1018027792
D
These shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive one ordinary share, par value $0.0001. 50% of the RSUs shall vest on March 28, 2025, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
/s/ Rachelle Jacques
2024-04-30